Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Koninklijke Philips N.V.NYSE: PHG

Operating Income · Q2 FY2026 · quarter ended Jun 2026

Operating income grows, but more slowly than its trailing trend

Q2 FY2026 operating income of €610M rose 52.5% year over year, behind the +57.9% change in trailing-twelve-month operating income. Sequentially, it rose 153.1% from the prior quarter.

Context

  • Operating income amounted to 8.0% of revenue in FY2025, up 5.0 pp from a year earlier.
  • Operating income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 10 analysts of €2.56B (+80.1%) for the fiscal year ending Dec 2026, a slowdown from the +169.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
€610M+153.1% QoQ
Last fiscal yearDec 2025
€1.42B+169.2% YoY
LTMJun 2026
€1.72B+57.9% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+52.5%+71.1%+18.6 pp
1 year+169.2%+80.1%-89.1 pp
3-year CAGR—+26.2%—
5-year CAGR+18.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

EUR · from the income statement

Latest · FY2025
1.42B EUR
Year-over-year change
+169.2%
4-year CAGR
+26.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +57.9% is the highest of 10, against a peer median of +12.3%.
  • Operating income amounts to 9.7% of revenue for PHG, versus a peer median of 16.8%.
PHG Competitors
Operating Income for PHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Sep 2026$7.35B USD-5.6%-1.3%15.2%
MDTMedtronic plcLTM Jul 2026$6.79B USD+10.8%+5.6%18.1%
BSXBoston Scientific CorporationLTM Jun 2026$4.51B USD+51.3%+29.6%21.5%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$2.57B USD-6.8%+3.1%12.7%
RMDResMed Inc.LTM Jun 2026$1.89B USD+12.3%+19.0%33.5%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.72B EUR+57.9%—9.7%
SNNSmith & Nephew plcFY2025$794M USD+20.9%+20.8%12.9%
LIVNLivaNova PLCLTM Sep 2026$172.7M USD-10.9%—11.5%
IRMDIRadimed CorporationLTM Mar 2026$27.95M USD+23.4%+18.7%32.4%
NPCENeuroPace, Inc.LTM Mar 2026-$16.76M USD+13.0%—16.8%
Peer median (excluding PHG) —+12.3%+18.7%16.8%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.